We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. A cost-benefit analysis of genetic screening test for breast cancer in Iran

    Background

    This study aimed to evaluate the implementation of the population- and family history (FH) -based screening for BReast CAncer (BRCA) in...

    Zahra Meshkani, Najmeh Moradi, ... Nazi Moini in BMC Cancer
    Article Open access 01 March 2024
  2. Benefit worth the cost

    Article 15 December 2023
  3. Abbott realtime MTB assay for detecting Mycobacterium tuberculosis complex in respiratory specimens: a cost-benefit analysis

    Purpose

    Molecular screening for Mycobacterium tuberculosis (MTB) can lead to rapid empirical treatment inception and reduce hospitalization time and...

    Josep Ferrer, Estela Giménez, ... Eliseo Albert in European Journal of Clinical Microbiology & Infectious Diseases
    Article 03 July 2024
  4. Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies

    Introduction

    Proprotein convertase subtilisin/kexin 9 inhibitors (PCSK9i) are monoclonal antibodies that lower lipid levels. Although several...

    Bhavani Shankara Bagepally, Akhil Sasidharan in European Journal of Clinical Pharmacology
    Article 27 October 2021
  5. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer

    Background

    Proton therapy is a promising advancement in radiation oncology especially in terms of reducing normal tissue toxicity, although it is...

    N. Patrik Brodin, Rafi Kabarriti, ... Wolfgang A. Tomé in Radiation Oncology
    Article Open access 21 January 2021
  6. Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology

    In this commentary, using existing clinical trial data and FDA approvals we propose that there is currently a critical need for an appropriate...

    Tomer Meirson, Valerio Nardone, ... Luciano Mutti in Journal of Translational Medicine
    Article Open access 13 December 2022
  7. Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding

    Introduction

    New approaches are being developed to early detect endometrial cancer using molecular biomarkers. These approaches offer high...

    Paula Peremiquel-Trillas, David GĂłmez, ... Mireia DĂ­az in British Journal of Cancer
    Article Open access 10 May 2023
  8. Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

    Background

    A national, lung cancer screening programme is under consideration in Australia, and we assessed cost-effectiveness using updated data and...

    Silvia Behar Harpaz, Marianne F. Weber, ... Karen Canfell in British Journal of Cancer
    Article Open access 03 November 2022
  9. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data

    The objective of this study was to estimate the cost-effectiveness of CYP3A5 genotype-guided tacrolimus dosing in kidney, liver, heart, and lung...

    Kimberly M. Deininger, Heather D. Anderson, ... Christina L. Aquilante in The Pharmacogenomics Journal
    Article 15 May 2024
  10. Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis

    Early trials of novel vaccines against tuberculosis (TB) in adults have suggested substantial protection against TB. However, little is known about...

    Sahan Jayawardana, Chathika K. Weerasuriya, ... Miqdad Asaria in npj Vaccines
    Article Open access 07 November 2022
  11. Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

    Background

    Serplulimab is a potential valuable therapy, while patients, physicians, and decision-makers are uncertain about the cost-effectiveness of...

    Taihang Shao, Mingye Zhao, ... Wenxi Tang in BioDrugs
    Article 25 February 2023
  12. Cost-utility analysis of a structured medication review compared to usual care in Parkinson’s disease

    Purpose

    For controlling symptoms in Parkinson’s disease (PD) together with treating additional comorbidities, patients often face complex medication...

    N. G. M. Oonk, L. D. A. Dorresteijn, ... H. Koffijberg in European Journal of Clinical Pharmacology
    Article 23 December 2022
  13. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care

    Genomic research is driving discovery for future population benefit. Limited evidence exists on immediate patient and health system impacts of...

    Deirdre Weymann, Janessa Laskin, ... Dean A. Regier in Journal of Community Genetics
    Article 29 November 2021
  14. Design and analysis of polycentric prosthetic knee with enhanced kinematics and stability

    This paper describes a continuation of earlier work using the finite element method to conduct an engineering failure analysis of an existing...

    Rajesh Kumar Mohanty, Ramesh Chandra Mohanty, Sukanta Kumar Sabut in Physical and Engineering Sciences in Medicine
    Article 02 January 2023
  15. Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis

    Background

    Radical resection is still the most cost-effectiveness curative strategy for intrahepatic cholangiocarcinoma (ICC), but it remains...

    Qiao Ke, Lei Wang, ... Yongyi Zeng in BMC Cancer
    Article Open access 11 September 2023
  16. CT ventilation image-guided helical Tomotherapy at sparing functional lungs for locally advanced lung cancer: analysis of dose-function metrics and the impact on pulmonary toxicity

    Purpose

    CT ventilation image (CTVI)-guided radiotherapy that selectively avoids irradiating highly-functional lung regions has potential to reduce...

    Shuangshuang Li, Juan Liu, ... Zhen Hou in Radiation Oncology
    Article Open access 09 January 2023
  17. Pharmacoeconomic Analysis Methods

    In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic...
    Living reference work entry 2022
  18. Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada

    Introduction

    While no direct comparative data exist for crizotinib in ROS1+ non-small cell lung cancer (NSCLC), studies have suggested clinical...

    Jaclyn M. Beca, Shaun Walsh, ... Kelvin K. W. Chan in BMC Cancer
    Article Open access 29 October 2021
  19. Applications of Model-Based Meta-Analysis in Drug Development

    Model-based meta-analysis (MBMA) is a quantitative approach that leverages published summary data along with internal data and can be applied to...

    Phyllis Chan, Kirill Peskov, Xuyang Song in Pharmaceutical Research
    Article Open access 16 February 2022
Did you find what you were looking for? Share feedback.